---
title: "Adial Pharmaceuticals, Inc. (ADIL.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADIL.US.md"
symbol: "ADIL.US"
name: "Adial Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-20T18:20:00.551Z"
locales:
  - [en](https://longbridge.com/en/quote/ADIL.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADIL.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADIL.US.md)
---

# Adial Pharmaceuticals, Inc. (ADIL.US)

## Company Overview

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company’s lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.adial.com](https://www.adial.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.38 | 81 | - | - | - |
| PB | 0.79 | 35 | 2.12 | 1.42 | 0.53 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T04:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 50% |
| Overweight | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.23 |
| Highest Target | 42.00 |
| Lowest Target | 8.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ADIL.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ADIL.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ADIL.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ADIL.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**